Yield and Utility of Routine Epilepsy Panel Genetic Testing Among Young Patients With Seizures

Emily Grew1, Mayuri Reddy1, Hayley Reichner1

  • 1Rutgers New Jersey Medical School, Newark, NJ, USA.

PubMed

Insights

Routine epilepsy genetic testing in children under 8 years old yielded clinically relevant results, identifying pathogenic variants and variants of uncertain significance with implications for treatment and prognosis.

Area of Science:

  • Pediatric Neurology
  • Clinical Genetics

Background:

  • Epilepsy is a common neurological disorder in children.
  • Genetic factors play a significant role in the etiology of pediatric epilepsy.
  • Advances in genetic testing offer new diagnostic possibilities.

Purpose of the Study:

  • To evaluate the diagnostic yield of routine epilepsy genetic panel testing in pediatric patients.
  • To identify predictors of positive genetic testing results in children with epilepsy.

Main Methods:

  • Retrospective review of epilepsy genetic panel results from July 2021 to July 2023.
  • Inclusion of patients under 8 years old.
  • Analysis of demographics, clinical features, family history, EEG, and MRI findings.

Main Results:

  • 65 pediatric patients were included (mean age 4.5 years).
  • Pathogenic variants were found in 16.9%, carriers for autosomal recessive conditions in 10.8%, and variants of uncertain significance in 55.4%.
  • No association was found between genetic results and clinical features, demographics, or imaging.

Conclusions:

  • Epilepsy genetic panels provide clinically relevant findings in pediatric patients.
  • Identified variants have implications for treatment, comorbidity screening, reproduction, and prognostication.
  • Routine genetic screening is valuable for diagnosing the cause of epilepsy in children.